SAILIFE Stock Overview

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. More details

SAILIFE fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	4/6
Past Performance	5/6
Financial Health	4/6
Dividends	0/6

Rewards

Earnings are forecast to grow 28.67% per year

Earnings grew by 113.3% over the past year

Risk Analysis

Has a high level of debt

Significant insider selling over the past 3 months

Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

Sai Life Sciences Limited Competitors

Indegene

NSEI:INDGN

₹136.4b

Syngene International

NSEI:SYNGENE

₹291.7b

Akums Drugs and Pharmaceuticals

NSEI:AKUMS

₹76.5b

Innova Captab

NSEI:INNOVACAP

₹52.3b

Price History & Performance

Summary of share price highs, lows and changes for Sai Life Sciences
Historical stock prices
Current Share Price	₹721.50
52 Week High	₹808.80
52 Week Low	₹636.10
Beta	0
1 Month Change	3.28%
3 Month Change	0.70%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-5.64%

Recent updates

Shareholder Returns

	SAILIFE	IN Life Sciences	IN Market
7D	12.7%	7.5%	5.3%
1Y	n/a	40.8%	2.1%

Return vs Industry: Insufficient data to determine how SAILIFE performed against the Indian Life Sciences industry.

Return vs Market: Insufficient data to determine how SAILIFE performed against the Indian Market.

Price Volatility

Is SAILIFE's price volatile compared to industry and market?
SAILIFE volatility
SAILIFE Average Weekly Movement	8.0%
Life Sciences Industry Average Movement	8.0%
Market Average Movement	7.3%
10% most volatile stocks in IN Market	9.9%
10% least volatile stocks in IN Market	4.9%

Stable Share Price: SAILIFE has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine SAILIFE's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1999	3,135	Krishnam Kanumuri	www.sailife.com

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. The company offers medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006.

Sai Life Sciences Limited Fundamentals Summary

How do Sai Life Sciences's earnings and revenue compare to its market cap?
SAILIFE fundamental statistics
Market cap	₹150.38b
Earnings (TTM)	₹1.38b
Revenue (TTM)	₹15.54b

109.0x

P/E Ratio

9.7x

P/S Ratio

Is SAILIFE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SAILIFE income statement (TTM)
Revenue	₹15.54b
Cost of Revenue	₹4.61b
Gross Profit	₹10.94b
Other Expenses	₹9.56b
Earnings	₹1.38b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	6.62
Gross Margin	70.37%
Net Profit Margin	8.88%
Debt/Equity Ratio	95.1%

How did SAILIFE perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/17 23:09
End of Day Share Price	2025/04/17 00:00
Earnings	2024/12/31
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sai Life Sciences Limited is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Rahul Jeewani	IIFL Research
Alok Dalal	Jefferies LLC
Kawaljeet Saluja	Kotak Securities (Institutional Equities)

Sai Life Sciences NSEI:SAILIFE Stock Report